Cite
MLA Citation
J.L. Gulley et al.. “3090 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or recurrent non-small-cell lung cancer progressing after platinum-based chemotherapy: A phase Ib trial.” European journal of cancer, vol. 51, n.d., pp. S629–. http://access.bl.uk/ark:/81055/vdc_100030628321.0x00003c